Jul 11, 2024 | Laboratory UTCBS, Symposium
UTCBS presents its work at the international congress of the “controlled release society” in Bologna. The UTCBS team has shown the interest of nanoparticles both for the imaging of ROS in vivo and the promotion of antioxydant therapeutic activity....
Jun 20, 2024 | Laboratory UTCBS
The Alnylam Pharmaceuticals 2024 “Interfering RNA & Rare Diseases” Prize has been awarded to Virginie Escriou, for her research entitled “Therapeutic strategies based on orally administered siRNA”. The prize was delivered at the Annual...
Jun 14, 2024 | Laboratory UTCBS, Research
On Friday June 7, the UTCBS students’ day took place at the Faculty of Pharmacy, organized by the laboratory’s PhD students. The day was an opportunity for students and post-docs to talk about their studies and training. During the event, we had the...
May 3, 2024 | Laboratory UTCBS, Research
The LHF Espoir and Artistes Sportifs de Coeur associations presented a cheque to the biotherapy team to support its research project, which aims to administer mRNA to restore the expression of the missing protein in genetic diseases such as Microvillous Inclusion...
Apr 11, 2024 | Laboratory UTCBS, Research
The Biotherapy team, in collaboration with the Nanobiosciences and microsystems team of unit 8640 of the CNRS (P.A.S.T.E.U.R) of the Ecole Normale Supérieure, has just published an article in the Journal of the American Chemical Society on the intracellular...
Feb 22, 2024 | Laboratory UTCBS, Research
A disease is considered rare when it affects less than 1 in 2,000 people. There are around 7,000 such diseases, affecting 3 million people in France. But most of these diseases are still shrouded in secrecy: the cause of more than half of them is unknown, which...
